New Publication: The regulatory gap in digital health and bridging it via alternative pathways

A debate on regulating digital health and artificial intelligence in medicine has recently been picking up steam. In this new original research article just published, DSI researcher Jeffrey David Iqbal and DSI member Nicola Biller-Adorno describe key differences between both digital health products and classical medical devices & drugs as well as digital health actors and established healthcare actors.